Cancer-specific enhancer-associated dilncRNAs (ECEPs) such as PAX6-AS1 and KCNC2-AS1 contain conserved intronic stem-loop structures absent in non-cancer cells due to alternative splicing. ASOs targeting these conserved structured regions would preferentially disrupt oncogenic enhancer function (BET proteins, Mediator complex scaffolding) and reduce BRD4 occupancy at MYC enhancers. Limited data available; hypothesis requires systematic mapping and validation.
**Background and Rationale**
Alzheimer's disease (AD) pathogenesis is intimately linked to apolipoprotein E (APOE) isoform-dependent differences in amyloid-beta (Aβ) clearance and lipid metabolism. The APOE4 allele, present in approximately 25% of the population and 65% of AD patients, confers the highest genetic risk for late-onset AD. Unlike APOE2 and APOE3, APOE4 exhibits significantly reduced lipidation capacity and impaired Aβ clearance efficiency. This stems from structural differences in
Verdict Summary
3/10
dimensions won
Structured Intronic Scaffold Regions in
7/10
dimensions won
miR-33 Antisense Oligonucleotide Hyper-L
Radar Chart — 10 Dimensions
Score Comparison Bars
Mechanistic
0.45
0.70
Evidence
0.42
0.75
Novelty
0.82
0.70
Feasibility
0.38
0.51
Impact
0.55
0.65
Druggability
0.48
0.55
Safety
0.52
0.45
Competition
0.70
0.50
Data
0.35
0.70
Reproducible
0.42
0.65
Score Breakdown
Dimension
Structured Intronic Scaffold R
miR-33 Antisense Oligonucleoti
Mechanistic
0.450
0.700
Evidence
0.420
0.750
Novelty
0.820
0.700
Feasibility
0.380
0.510
Impact
0.550
0.650
Druggability
0.480
0.550
Safety
0.520
0.450
Competition
0.700
0.500
Data
0.350
0.700
Reproducible
0.420
0.650
Evidence
Structured Intronic Scaffold Regions in Enhancer-dilncRNAs E